QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS
申请人:Allen Daniel Rees
公开号:US20110105508A1
公开(公告)日:2011-05-05
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.